Drug Safety and Availability. FDA alerts drug makers of a recall of porcine thyroid API from Sichuan Friendly Pharmaceutical Co., Limited, China. 2018. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-alerts-drug-makers-recall-porcine-thyroid-api-sichuan-friendly-pharmaceutical-co-limited-china (accessed on January27, 2020).
2.
MeyerLM, StephensK, CarterCA, PickardW, JohnsonPR, Eagerton DH 2020 Stability and consistency of compounded oral liquid levothyroxine formulations. J Am Pharm AssocS1544-3191(20)30250-8. DOI: 10.1016/j.japh.2020.05.014.
3.
Pappy IIAL, OyesikuN, IoachimescuA. 2016. Severe TSH elevation and pituitary enlargement after changing thyroid replacement to compounded T4/T3 therapy. J Investig Med High Impact Case Rep, 4:1–7.
4.
ShahKK, MbughuniMM, BurgstalerEA, BlockDR, WintersJL. 2017. Iatrogenic thyrotoxicosis and the role of therapeutic plasma exchange. J Clin Apher, 32:579–583.
5.
HeZH, LiY, TrivediN, GillS, HennesseyJV. 2020. Thyrotoxicosis after massive triiodothyronine (LT3) overdose: a coast-to-coast case series and review. Drugs Context, 9:2019-8-4.
6.
FederalFood, Drug, and CosmeticAct, 21 U.S.C. Sect. 353a 2013. Available at https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section353a&num=0&edition=prelim (accessed on May26, 2020).
